Filtros de búsqueda

Lista de obras de

2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes 2006.

artículo científico publicado en 2008

2011 Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS) 2006.

artículo científico publicado en 2011

A randomised study of three different informational AIDS prior to coronary angiography, measuring patient recall, satisfaction and anxiety.

artículo científico publicado en 2007

A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 hours after recombinant tissue-type plasminogen activator for acute myocardial infarction. National Heart Foundation of Australia Coronary Thrombolysis Group

artículo científico publicado en 1991

Adrenaline facilitates neurogenic vasoconstriction in borderline hypertensive subjects.

artículo científico publicado en 1990

Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial

artículo científico publicado en 1996

Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial

artículo científico publicado en 2016

Apixaban in patients with atrial fibrillation and prior coronary artery disease: insights from the ARISTOTLE trial

artículo científico publicado en 2013

Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial

artículo científico publicado en 2013

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

artículo científico publicado en 2022

Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar

artículo científico publicado en 2015

Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial).

artículo científico publicado en 2013

Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis

artículo científico publicado en 2008

Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction

artículo científico

Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program

artículo científico publicado en 2012

Baroreflex control of myocardial contractility in conscious normotensive and renal hypertensive rabbits

artículo científico publicado en 1983

Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention

artículo científico publicado en 2009

Bivalirudin for patients with acute coronary syndromes

artículo científico publicado en 2006

Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and gender

artículo científico publicado en 2002

Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial

scientific article published on 15 May 2020

Cardiac performance in the conscious rabbit with acute hypertension following brainstem lesions coinciding with the A1 group of catecholamine neurons

artículo científico publicado el 1 de agosto de 1984

Changes in left anterior descending coronary artery wall thickness detected by high resolution transthoracic echocardiography.

artículo científico publicado en 2008

Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

artículo científico publicado en 2017

Comparative haemodynamic effects of lidocaine, mexiletine, and disopyramide

artículo científico publicado el 1 de mayo de 1984

Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone

article

Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (S

artículo científico publicado en 2005

Complications of Defibrillation With Permanent Pacemaker in Situ ⬇️

artículo científico publicado el 1 de julio de 1979

Coronary Revascularization Surgery After Myocardial Infarction: Impact of Bypass Surgery on Survival After Thrombolysis

scientific article published on 01 February 1997

Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict

artículo científico publicado en 2008

Coronary artery wall thickness of the left anterior descending artery using high resolution transthoracic echocardiography--normal range of values.

artículo científico publicado en 2013

Corrigendum to 'National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016' Heart Lung and Circulation volume 25, (2016) 898 - 952.

artículo científico publicado en 2017

Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease

article

Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.

artículo científico publicado en 1986

Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction

artículo científico publicado en 2006

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

artículo científico publicado en 1999

Early statin initiation and outcomes in patients with acute coronary syndromes

artículo científico publicado en 2002

Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

artículo científico publicado en 2020

Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial

artículo científico

Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

artículo científico publicado en 2016

Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial

artículo científico publicado en 2013

Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial

artículo científico publicado en 2013

Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

scientific article published on 01 September 2019

Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial

artículo científico publicado en 2018

Effects of vasopressin on the circulation and its baroreflex control in healthy men.

artículo científico publicado en 1986

Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack: Results from TRA 2°P-TIMI 50.

artículo científico

Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery

artículo científico publicado en 2015

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation

artículo científico publicado en 2013

Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE

scientific article published on 06 June 2014

Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin,

artículo científico publicado en 2006

Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction

artículo científico publicado en 2001

Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial

artículo científico publicado en 2015

Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel

artículo científico

Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial

artículo científico publicado en 2010

Epinephrine facilitates neurogenic vasoconstriction in humans

artículo científico publicado en 1988

Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptoki

artículo científico publicado en 1995

Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

artículo científico publicado en 2014

Feasibility of identifying amyloid and hypertrophic cardiomyopathy with the use of computerized quantitative texture analysis of clinical echocardiographic data

artículo científico publicado en 1989

Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial).

artículo científico publicado en 2015

Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease

artículo científico publicado en 2016

Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial

artículo científico publicado en 2010

High-resolution transthoracic echocardiography of the left anterior descending coronary artery: a novel noninvasive assessment of coronary vasoreactivity

artículo científico publicado en 2007

High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial

artículo científico publicado en 2005

Improving cardiovascular health and quality of life in people with severe mental illness: study protocol for a randomised controlled trial.

artículo científico publicado en 2018

Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial

artículo científico publicado en 2014

Inhibition of muscle sympathetic nerve activity in humans by arginine vasopressin.

artículo científico publicado en 1987

Intensive LDL Reduction Post Acute Coronary Syndromes: A Catalyst for Improved Outcomes

artículo científico publicado en 2016

Invasive and antiplatelet treatment of patients with non-ST-segment elevation myocardial infarction: Understanding and addressing the global risk-treatment paradox

scientific article published on 17 July 2019

Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.

artículo científico publicado en 2015

Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy

artículo científico

Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial

artículo científico publicado en 2020

Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

artículo científico publicado en 2016

Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events: A Secondary Analysis of the PEGASUS-TIMI 54 Trial

artículo científico

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up

artículo científico publicado en 2002

Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial.

artículo científico publicado en 2014

Lp(a) and Cardiovascular Outcomes: an Analysis from the ODYSSEY OUTCOMES Trial

artículo científico publicado en 2018

Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial

artículo científico

National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016

artículo científico publicado en 2016

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016.

artículo científico publicado en 2016

New Antiplatelet Agents and the Role of Platelet Function Testing in Acute Coronary Syndromes ⬇️

artículo científico publicado el 1 de agosto de 2013

New ST-depression: an under-recognized high-risk category of 'complete' ST-resolution after reperfusion therapy

artículo científico publicado en 2012

Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial

artículo científico publicado en 2008

One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: results from the GUSTO-I trial

artículo científico publicado en 1999

Optimal size of cuff bladder for indirect measurement of arterial pressure in adults

artículo científico publicado en 1989

Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trial

article

Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial

artículo científico publicado en 2008

Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial)

scientific article published on 19 July 2018

Outcomes of cardiac surgery in Indigenous Australians.

artículo científico publicado en 2009

Paroxysmal hypertension due to sinoaortic baroreceptor denervation in humans

artículo científico publicado en 1987

Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes

artículo científico publicado en 2005

Plasma surfactant protein-B: a novel biomarker in chronic heart failure.

artículo científico publicado en 2004

Postexercise hypotension and sympathoinhibition in borderline hypertensive men

artículo científico publicado en 1989

Practical experience with ticagrelor: an Australian and New Zealand perspective

artículo científico

Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization ⬇️

artículo científico publicado el 25 de agosto de 2012

Pre-hospital thrombolysis in ST-segment elevation myocardial infarction: a regional Australian experience

artículo científico publicado en 2017

Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial

artículo científico publicado en 2008

Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators

artículo científico publicado en 1995

Predictors of statin-induced regression of left anterior descending coronary artery wall thickness as measured by high-resolution transthoracic echocardiography.

artículo científico publicado en 2012

Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease.

artículo científico publicado en 2008

Preventing recurrent events in survivors of acute coronary syndromes in Australia: consensus recommendations using the Delphi process

artículo científico publicado en 2017

Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.

artículo científico publicado en 2018

Prognostic value of lead V1 ST elevation during acute inferior myocardial infarction

artículo científico publicado en 2010

Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators

artículo científico publicado en 1999

QRS duration alone misses cardiac dyssynchrony in a substantial proportion of patients with chronic heart failure

artículo científico publicado en 2006

Randomized Comparison of High-Sensitivity Troponin Reporting in Undifferentiated Chest Pain Assessment.

artículo científico

Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin–Coronary Artery Disease Trial

artículo científico

Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators

artículo científico publicado en 1997

Rationale and design of ApoA-I event reducing in ischemic syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute my

artículo científico publicado en 2020

Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial.

artículo científico

Recurrent Ischemia After Thrombolysis: Importance of Associated Clinical Findings fn1fn1This study was supported by grants from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California; ICI Pharmace

artículo científico publicado en 1998

Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER.

artículo científico publicado en 2014

Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators

artículo científico publicado en 1996

Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIA

artículo científico publicado en 2008

Relation of pathologic Q waves at presentation and time to streptokinase therapy with early changes in infarct-related artery flow and ventricular wall motion

artículo científico publicado en 2001

Relative roles of vagal and sympathetic effector mechanisms in the baroreflex control of myocardial contractility in conscious rabbits

artículo científico publicado en 1985

Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI Angiographic Study

scientific article published on 27 March 2008

Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".

artículo científico publicado en 2014

Risk Markers of Incident Atrial Fibrillation in Patients with Coronary Heart Disease

scientific article published on 02 January 2021

Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin–Acute Coronary Syndromes Trial

artículo científico

Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease

artículo científico publicado en 2017

Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators

artículo científico publicado en 1999

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

artículo científico publicado en 1999

Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome.

artículo científico publicado en 2008

Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects

artículo científico publicado en 2020

Status of PCSK9 Monoclonal Antibodies in Australia

artículo científico publicado en 2019

Streptokinase morbidity--more common than previously recognised

artículo científico publicado el 1 de abril de 1992

Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial

artículo científico publicado en 2018

Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries

artículo científico publicado en 1995

Study design of embracing high-sensitivity troponin effectively: the value of more information: a randomized comparison

artículo científico publicado en 2014

Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome

artículo científico publicado en 2016

Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial

artículo científico publicado en 2010

Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial

artículo científico publicado en 2000

The National Emergency Access Target (NEAT): can quality go with timeliness? ⬇️

artículo científico publicado el 18 de febrero de 2013

The Study Of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): Design and rationale

artículo científico publicado en 2012

The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry

artículo científico publicado en 2006

The current status of thrombolytic therapy ⬇️

artículo científico publicado el 1 de agosto de 1997

The effect of coronary angioplasty on coronary flow reserve

artículo científico publicado en 1988

The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis.

artículo científico publicado en 2016

The potential role of anticoagulant therapy for the secondary prevention of ischemic events post-acute coronary syndrome.

artículo científico publicado en 2014

The role of antiplatelet therapy in the secondary prevention of coronary artery disease.

artículo científico publicado en 2010

The use of intravenous enoxaparin in elective percutaneous coronary intervention in patients with renal impairment: results from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial

artículo científico publicado en 2008

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

artículo científico publicado en 2011

Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial

artículo científico publicado en 2001

Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease

artículo científico publicado en 2016

Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial

artículo científico

Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators

artículo científico publicado en 1996

Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial

artículo científico publicado en 2007

Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

artículo científico publicado en 2017

Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial

artículo científico publicado en 2007

Ultrasound characterization of acute myocardial ischemia by quantitative texture analysis

scientific article published on 01 October 1986

Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial

artículo científico publicado en 2010

Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: Results of GUSTO-I

scientific article published on 01 November 1998

Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial

artículo científico publicado en 2010

Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial

artículo científico publicado en 2016

Use of ticagrelor alongside fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Practical perspectives based on data from the TREAT study

artículo científico publicado en 2018

Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial).

artículo científico publicado en 2014

Usefulness of the presenting electrocardiogram in predicting successful reperfusion with streptokinase in acute myocardial infarction

artículo científico publicado en 1999

Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial

artículo científico publicado en 2016

Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial

artículo científico publicado en 2017

Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).

artículo científico publicado en 2013

Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER).

artículo científico publicado en 2014

Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial

artículo científico publicado en 2014

Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda